Richard Newitter
Stock Analyst at Truist Financial
(4.19)
# 1,532
Out of 5,004 analysts
1034
Total ratings
47.7%
Success rate
5.9%
Average return
Main Sectors:
Stocks Rated by Richard Newitter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BBNX Beta Bionics | Rated: Buy | $23 → $28 | $21.51 | +30.17% | 16 | Sep 24, 2026 | |
| MMED MiniMed Group | Initiated Coverage: Buy | $29 | $19.98 | +45.15% | 1 | Sep 24, 2026 | |
| TNDM Tandem Diabetes Care | Rated: Buy | $31 → $28 | $15.72 | +78.12% | 10 | Sep 24, 2026 | |
| DXCM DexCom | Reiterated: Buy | $102 | $86.62 | +17.76% | 13 | Sep 23, 2026 | |
| ZBH Zimmer Biomet Holdings | Reiterated: Hold | $106 | $91.04 | +16.43% | 73 | Sep 16, 2026 | |
| BSX Boston Scientific | Reiterated: Buy | n/a | $43.92 | - | 54 | Sep 9, 2026 | |
| MDT Medtronic | Reiterated: Hold | $86 → $99 | $88.64 | +11.69% | 49 | Sep 2, 2026 | |
| VCEL Vericel | Reiterated: Buy | n/a | $39.71 | - | 20 | Aug 20, 2026 | |
| IRTC iRhythm Holdings | Reiterated: Buy | n/a | $110.38 | - | 35 | Aug 19, 2026 | |
| TMCI Treace Medical Concepts | Reiterated: Hold | $4 → $5 | $4.50 | +11.11% | 37 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 | $74.52 | +34.19% | 56 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 → $20 | $15.10 | +32.45% | 8 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $210 → $153 | $136.13 | +12.39% | 16 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $21 | $17.20 | +22.09% | 42 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $54 → $62 | $70.50 | -12.06% | 67 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $110 → $127 | $126.34 | +0.52% | 19 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $125 → $103 | $99.74 | +2.77% | 60 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 → $23 | $18.59 | +23.72% | 17 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $330 → $340 | $272.36 | +24.83% | 49 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $180 → $215 | $154.43 | +39.22% | 24 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $95 | $86.29 | +10.09% | 41 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $580 → $510 | $405.18 | +25.87% | 73 | Jul 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $20 | $22.55 | -11.31% | 17 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $122.07 | - | 65 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $53.63 | - | 1 | Jan 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $370 → $374 | $318.89 | +17.28% | 27 | Jan 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $13 | $16.12 | -19.35% | 33 | Dec 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $111.95 | n/a | 1 | Jun 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $19.79 | n/a | 1 | Jun 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $237.95 | n/a | 1 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $11.62 | n/a | 1 | Jun 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $25.44 | n/a | 1 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $148 | $169.55 | n/a | 1 | Aug 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.41 | n/a | 10 | Oct 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $4.66 | n/a | 3 | Sep 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | CHF 58.80 → CHF 66.45 | CHF 53.30 | n/a | 11 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $172.79 | n/a | 4 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 | $43.39 | n/a | 13 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $260 → $250 | $183.82 | n/a | 16 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $6.92 | n/a | 3 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $770 | $146.78 | n/a | 26 | Jul 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $141 | $45.38 | n/a | 14 | Jul 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $45 | $101.29 | n/a | 1 | Jul 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $58.38 | n/a | 1 | Jul 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $47 | $23.37 | n/a | 1 | Jul 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $140 | $271.22 | n/a | 1 | Jul 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $4.5 | $10.00 | n/a | 1 | Jul 15, 2016 |
Beta Bionics
Sep 24, 2026
Rated: Buy
Price Target: $23 → $28
Current: $21.51
Upside: +30.17%
MiniMed Group
Sep 24, 2026
Initiated Coverage: Buy
Price Target: $29
Current: $19.98
Upside: +45.15%
Tandem Diabetes Care
Sep 24, 2026
Rated: Buy
Price Target: $31 → $28
Current: $15.72
Upside: +78.12%
DexCom
Sep 23, 2026
Reiterated: Buy
Price Target: $102
Current: $86.62
Upside: +17.76%
Zimmer Biomet Holdings
Sep 16, 2026
Reiterated: Hold
Price Target: $106
Current: $91.04
Upside: +16.43%
Boston Scientific
Sep 9, 2026
Reiterated: Buy
Price Target: n/a
Current: $43.92
Upside: -
Medtronic
Sep 2, 2026
Reiterated: Hold
Price Target: $86 → $99
Current: $88.64
Upside: +11.69%
Vericel
Aug 20, 2026
Reiterated: Buy
Price Target: n/a
Current: $39.71
Upside: -
iRhythm Holdings
Aug 19, 2026
Reiterated: Buy
Price Target: n/a
Current: $110.38
Upside: -
Treace Medical Concepts
Aug 10, 2026
Reiterated: Hold
Price Target: $4 → $5
Current: $4.50
Upside: +11.11%
Aug 7, 2026
Reiterated: Buy
Price Target: $100
Current: $74.52
Upside: +34.19%
Aug 6, 2026
Reiterated: Buy
Price Target: $18 → $20
Current: $15.10
Upside: +32.45%
Aug 6, 2026
Downgraded: Hold
Price Target: $210 → $153
Current: $136.13
Upside: +12.39%
Aug 5, 2026
Reiterated: Hold
Price Target: $21
Current: $17.20
Upside: +22.09%
Aug 4, 2026
Reiterated: Hold
Price Target: $54 → $62
Current: $70.50
Upside: -12.06%
Aug 4, 2026
Downgraded: Hold
Price Target: $110 → $127
Current: $126.34
Upside: +0.52%
Aug 4, 2026
Downgraded: Hold
Price Target: $125 → $103
Current: $99.74
Upside: +2.77%
Aug 4, 2026
Reiterated: Buy
Price Target: $21 → $23
Current: $18.59
Upside: +23.72%
Jul 31, 2026
Reiterated: Hold
Price Target: $330 → $340
Current: $272.36
Upside: +24.83%
Jul 30, 2026
Reiterated: Buy
Price Target: $180 → $215
Current: $154.43
Upside: +39.22%
Jul 24, 2026
Reiterated: Hold
Price Target: $95
Current: $86.29
Upside: +10.09%
Jul 17, 2026
Reiterated: Buy
Price Target: $580 → $510
Current: $405.18
Upside: +25.87%
Mar 2, 2026
Reiterated: Hold
Price Target: $20
Current: $22.55
Upside: -11.31%
Feb 27, 2026
Reiterated: Hold
Price Target: n/a
Current: $122.07
Upside: -
Jan 16, 2026
Reiterated: Buy
Price Target: n/a
Current: $53.63
Upside: -
Jan 16, 2026
Downgraded: Hold
Price Target: $370 → $374
Current: $318.89
Upside: +17.28%
Dec 23, 2025
Reiterated: Hold
Price Target: $13
Current: $16.12
Upside: -19.35%
Jun 26, 2025
Reiterated: Buy
Price Target: n/a
Current: $111.95
Upside: n/a
Jun 18, 2025
Reiterated: Buy
Price Target: n/a
Current: $19.79
Upside: n/a
Oct 16, 2024
Rated: Buy
Price Target: n/a
Current: $237.95
Upside: n/a
Jun 20, 2024
Rated: Buy
Price Target: n/a
Current: $11.62
Upside: n/a
Apr 17, 2024
Reiterated: Buy
Price Target: n/a
Current: $25.44
Upside: n/a
Aug 22, 2023
Reiterated: Hold
Price Target: $148
Current: $169.55
Upside: n/a
Oct 7, 2021
Reiterated: Buy
Price Target: n/a
Current: $1.41
Upside: n/a
Sep 10, 2021
Initiated Coverage: Buy
Price Target: $20
Current: $4.66
Upside: n/a
Aug 17, 2021
Reiterated: Hold
Price Target: CHF 58.80 → CHF 66.45
Current: CHF 53.30
Upside: n/a
Aug 6, 2021
Rated: Buy
Price Target: n/a
Current: $172.79
Upside: n/a
Aug 5, 2021
Reiterated: Buy
Price Target: $27
Current: $43.39
Upside: n/a
Aug 5, 2021
Rated: Hold
Price Target: $260 → $250
Current: $183.82
Upside: n/a
Aug 5, 2021
Reiterated: Buy
Price Target: $20
Current: $6.92
Upside: n/a
Jul 28, 2021
Rated: Buy
Price Target: $770
Current: $146.78
Upside: n/a
Jul 28, 2021
Rated: Hold
Price Target: $141
Current: $45.38
Upside: n/a
Jul 15, 2016
Rated: Hold
Price Target: $45
Current: $101.29
Upside: n/a
Jul 15, 2016
Reiterated: Buy
Price Target: $20
Current: $58.38
Upside: n/a
Jul 15, 2016
Rated: Hold
Price Target: $47
Current: $23.37
Upside: n/a
Jul 15, 2016
Rated: Buy
Price Target: $140
Current: $271.22
Upside: n/a
Jul 15, 2016
Rated: Buy
Price Target: $4.5
Current: $10.00
Upside: n/a